NCT00791102 - Topical ASP-1001 (Contrast Media Formulation) and the Acute Response to Nasal Allergen Challenge (NAC) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

September 30, 2010

Study Completion Date

December 31, 2010

Conditions

Allergic Rhinitis

Interventions

DRUG

ASP-1001 nasal spray

2 sprays (total 200 microliters) in each nostril 20 minutes before allergen challenge.

DRUG

Placebo for ASP-1001

2 sprays (total 200 microliters) in each nostril 20 minutes before allergen challenge.

Trial Locations (1)

University of Chicago Medical Center, Chicago